SECOND INTERNATIONAL CONFERENCE ON IMMUNOLOGY AND AGING

第二届国际免疫学与衰老会议

基本信息

项目摘要

Current scientific investigation is significantly expanding our understanding of the changes in immune function that occur over the life span, especially by introducing more precise cellular and molecular biological approaches. The Institute for Advanced Studies in Immunology & Aging (IASIA), a non- profit, non-governmental organization located in Washington, DC, has as its mission to accelerate the pace of scientific discovery regarding the mysteries of the immune system and its relationship to the aging process. Evaluations of IASIA's First International Conference on Immunology and Aging mandated that IASIA again form a committee to organize a second meeting with an international representation to facilitate future research development and practice. The IASIA convened an organizing committee and, in collaboration with the World Health Organization and numerous other governmental and non- governmental groups, has developed a program plan for the proposed second international conference. The conference goal is to promote and facilitate research in immunology and aging. The program is designed to bring together interdisciplinary scientists and health professionals from around the world; to focus discussion on specific topical areas most critical to research and clinical needs; to stimulate future international collaborative research; to promote dissemination of key conference presentations; and, to determine the effectiveness of the meeting design for future gatherings and networking. A key design aspect of the Conference is its emphasis on bridging research knowledge with new preventive and clinical approaches. The committee is committed to identifying minorities, women and handicapped scientists to participate. It is estimated that 450 or more international participants will attend the Conference.
当前的科学研究正在显著地扩展我们的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William B. Ershler其他文献

Prevention of cyclophosphamide-induced haemorrhagic cystitis by disulfiram
  • DOI:
    10.1007/bf00320708
  • 发表时间:
    1982-05-01
  • 期刊:
  • 影响因子:
    2.400
  • 作者:
    William B. Ershler;Miles P. Hacker;Richard Gamelli
  • 通讯作者:
    Richard Gamelli
Case Report: Granulocytic Sarcoma of the Anterior Mediastinum
  • DOI:
    10.1097/00000441-198511000-00005
  • 发表时间:
    1985-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Arnold Toback;Douglas J. Hasbrouck;John Blaustein;William B. Ershler
  • 通讯作者:
    William B. Ershler
Postviral Platelet-Activating Anti-PF4 Disorder Responsive to High-Dose Intravenous Immunoglobulin
高剂量静脉注射免疫球蛋白反应的病毒后血小板激活抗 PF4 疾病
Paraspinal mass and lower extremity weakness in a patient with thalassemia
地中海贫血患者的椎旁肿块和下肢无力
  • DOI:
    10.1182/blood.2024028049
  • 发表时间:
    2025-04-10
  • 期刊:
  • 影响因子:
    23.100
  • 作者:
    Chad Zik;William B. Ershler
  • 通讯作者:
    William B. Ershler
Crizanlizumab Use in Recurrent Neurologic Symptoms Attributed to Sickle Cell Disease Induced Moyamoya Syndrome
  • DOI:
    10.1182/blood-2022-170745
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Chad Zik;Sheinei Alan;William B. Ershler
  • 通讯作者:
    William B. Ershler

William B. Ershler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William B. Ershler', 18)}}的其他基金

2004 Conference on Advancing Cancer Care in Elderly
2004 年推进老年人癌症护理会议
  • 批准号:
    6887970
  • 财政年份:
    2005
  • 资助金额:
    $ 3.5万
  • 项目类别:
OSTEOPOROSIS TREATMENT IN THE NURSING HOME: NGRC TRIAL
疗养院骨质疏松症治疗:NGRC 试验
  • 批准号:
    6232365
  • 财政年份:
    2000
  • 资助金额:
    $ 3.5万
  • 项目类别:
INTERLEUKIN 6 AND OSTEOPOROSIS
白细胞介素 6 与骨质疏松症
  • 批准号:
    2330205
  • 财政年份:
    1996
  • 资助金额:
    $ 3.5万
  • 项目类别:
INTERLEUKIN 6 AND OSTEOPOROSIS
白细胞介素 6 与骨质疏松症
  • 批准号:
    2053292
  • 财政年份:
    1995
  • 资助金额:
    $ 3.5万
  • 项目类别:
INTERLEUKIN 6 AND OSTEOPOROSIS
白细胞介素 6 与骨质疏松症
  • 批准号:
    2053293
  • 财政年份:
    1995
  • 资助金额:
    $ 3.5万
  • 项目类别:
BIOLOGY OF AGING AND AGE RELATED DISEASES
衰老生物学和年龄相关疾病
  • 批准号:
    2048013
  • 财政年份:
    1991
  • 资助金额:
    $ 3.5万
  • 项目类别:
BIOLOGY OF AGING AND AGE RELATED DISEASES
衰老生物学和年龄相关疾病
  • 批准号:
    3530577
  • 财政年份:
    1991
  • 资助金额:
    $ 3.5万
  • 项目类别:
BIOLOGY OF AGING AND AGE RELATED DISEASES
衰老生物学和年龄相关疾病
  • 批准号:
    2048015
  • 财政年份:
    1991
  • 资助金额:
    $ 3.5万
  • 项目类别:
BIOLOGY OF AGING AND AGE RELATED DISEASES
衰老生物学和年龄相关疾病
  • 批准号:
    2048014
  • 财政年份:
    1991
  • 资助金额:
    $ 3.5万
  • 项目类别:
BIOLOGY OF AGING AND AGE RELATED DISEASES
衰老生物学和年龄相关疾病
  • 批准号:
    3530578
  • 财政年份:
    1991
  • 资助金额:
    $ 3.5万
  • 项目类别:

相似海外基金

MRI: Acquisition of a High-throughput Flow Cytometry for Health Science Research and Training
MRI:获取高通量流式细胞术用于健康科学研究和培训
  • 批准号:
    1919830
  • 财政年份:
    2019
  • 资助金额:
    $ 3.5万
  • 项目类别:
    Standard Grant
African Americans in Health Science Research: A University, Community, and Faith-
健康科学研究中的非裔美国人:大学、社区和信仰-
  • 批准号:
    8006154
  • 财政年份:
    2010
  • 资助金额:
    $ 3.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了